GlassScriptPhysician profile
Vaibhave Parikh
NPI 1053563163
$2,680.89
in general payments reported to CMS, 2019-2025
23 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $331 · 2021: $704 · 2022: $493 · 2023: $196 · 2024: $128 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $532.39 | 2019-2024 | Senza |
| Abbott Laboratories | $431.11 | 2019-2023 | Proclaim, Eterna |
| Medtronic USA, INC. | $426.39 | 2019-2020 | |
| Medtronic, INC. | $366.27 | 2021-2025 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $245.20 | 2019-2024 | Triluron |
| Boston Scientific Corporation | $155.01 | 2021-2025 | General - Pain Management |
| Globus Medical, INC. | $141.60 | 2025 | Senza |
| Abbvie INC. | $59.94 | 2023 | |
| Fujifilm Sonosite, INC. | $50.24 | 2019 | |
| Amgen INC. | $37.81 | 2022 | |
| Spinal Simplicity, LLC | $33.91 | 2022 | |
| Averitas Pharma INC. | $25.73 | 2025 | Qutenza |
| Teva Pharmaceuticals USA, INC. | $23.07 | 2019 | |
| Amniox Medical, INC. | $20.39 | 2020 | |
| Ossur Americas, INC. | $19.53 | 2024 | Miami J |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $16.75 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.21 | 2024 | Kristalose |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.91 | 2022 | |
| Stimwave Technologies Incorporated | $14.73 | 2021 | |
| Horizon Therapeutics Plc | $14.26 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.74 | 2021 | |
| Si-Bone, INC. | $12.40 | 2019 | |
| Depuy Synthes Sales INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vaibhave Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.